K. A. Malle Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 1.29 Cr
- Company Age 42 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 47.65 Cr
- Satisfied Charges ₹ 10.73 Cr
- Revenue Growth -14.13%
- Profit Growth -406.16%
- Ebitda -293.52%
- Net Worth -180.34%
- Total Assets -9.33%
About K. A. Malle Pharmaceuticals
K. A. Malle Pharmaceuticals Limited (KAMPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 11 May 1982 and has a history of 42 years and nine months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as K. A. Malle Leasing Company Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.29 Cr.
The company currently has active open charges totaling ₹47.65 Cr. The company has closed loans amounting to ₹10.73 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rahul Bhomavat, Divyakumar Jain, Shanu Podar, and One other member serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U70101MH1982PLC027110
- Company No.
027110
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 May 1982
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does K. A. Malle Pharmaceuticals Limited offer?
K. A. Malle Pharmaceuticals Limited offers a wide range of products and services, including ISO & Quality Management Consultants, Certification Services, Content Writing Service, Research Development Services.
Who are the key members and board of directors at K. A. Malle Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Bhomavat  | Director | 08-Jun-2018 | Current |
| Divyakumar Jain | Director | 08-Aug-2018 | Current |
| Shanu Podar | Director | 18-Feb-2008 | Current |
| Hemant Chaturvedi | Director | 08-Nov-2021 | Current |
Financial Performance of K. A. Malle Pharmaceuticals.
K. A. Malle Pharmaceuticals Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.13% decrease. The company also saw a substantial fall in profitability, with a 406.16% decrease in profit. The company's net worth observed a substantial decline by a decrease of 180.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of K. A. Malle Pharmaceuticals?
In 2023, K. A. Malle Pharmaceuticals had a promoter holding of 99.96% and a public holding of 0.03%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rahul Pharma LtdRahul Bhomavat, Divyakumar Jain and 1 more are mutual person
- R S Residency Private Limited
Rahul Bhomavat and Divyakumar Jain are mutual person
- Sai-Ashray Industries Limited
Rahul Bhomavat, Divyakumar Jain and 1 more are mutual person
- Nautilus Infotech Private Limited
Rahul Bhomavat and Divyakumar Jain are mutual person
- K A Malle Life Sciences Private Limited
Rahul Bhomavat and Divyakumar Jain are mutual person
Charges (Loans)
₹47.65 Cr
₹10.73 Cr
Charges Breakdown by Lending Institutions
- The Cosmos Co-Operative Bank Ltd : 46.65 Cr
- Standard Chartered Bank : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2008 | The Cosmos Co-Operative Bank Ltd | ₹46.65 Cr | Open |
| 06 Dec 1985 | Standard Chartered Bank | ₹1.00 Cr | Open |
| 09 Apr 2013 | The Cosmos Co-Operative Bank Ltd. | ₹5.00 M | Satisfied |
| 21 Apr 2012 | The Cosmos Co-Op Bank Ltd | ₹0.70 M | Satisfied |
| 23 Jul 2011 | The Cosmos Co-Op Bank Ltd | ₹7.50 M | Satisfied |
How Many Employees Work at K. A. Malle Pharmaceuticals?
K. A. Malle Pharmaceuticals has a workforce of 119 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of K. A. Malle Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped K. A. Malle Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
